Chromosome 3 open reading frame 85 (C3orf85)

Chromosome 3 open reading frame 85 (C3orf85) is a protein-coding gene in humans, producing a very short 44-amino acid protein, currently unreviewed and uncharacterized by major databases[2][3][5][6]. Its molecular weight is approximately 10.4 kDa[5]. To date, C3orf85 has not been functionally characterized in terms of molecular mechanism, protein family, or physiological pathways, and is not recognized as a drug target or a component of established cellular signaling or regulatory machinery[2][6]. Initial studies suggest a possible link to certain cancers (including gastric cancer) and nutritional status, but there is no clear evidence for a disease-specific mechanism[3]. Current literature classifies it alongside other ORF proteins whose roles in cell biology may exist but remain poorly defined[1][2][3]. Key insights: - C3orf85 is not currently a receptor, enzyme, transporter, transcription factor, or other well-defined druggable target. - It is sometimes mentioned in high-throughput clinical or proteomic studies as a potential biomarker, but findings are preliminary and have not been validated for clinical use[1][3]. - No known drugs interact with C3orf85, and no established mechanism of action or safety profile exists for interventions targeting this protein[3][6]. Summary: C3orf85 is an uncharacterized, very short human protein whose function, classification, and therapeutic relevance remain undetermined. It is not considered a canonical drug target, and information remains limited to gene/protein sequence and cancer profiling studies[2][3][5][6].

Other names

C3orf85Uncharacterized protein C3orf85FLJ22763

None known